Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Chemotherapy Treatment for Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin
- Status
- WITHDRAWN
- Phase
- PHASE2
Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers
- Status
- COMPLETED
- Phase
- PHASE2